{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:12:00Z","timestamp":1792005120037,"version":"4.4.0"},"reference-count":19,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2011,3,29]],"date-time":"2011-03-29T00:00:00Z","timestamp":1301356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Abdominal Non-Hodgkin lymphomas (NHL) are the most common extra nodal presentation of pediatric NHL. Our aim is to assess the role of surgery as a risk factor and to evaluate the impact of risk-adjusted systemic chemotherapy on survival of patients with stages II and III disease. This study included 35 pediatric patients with abdominal NHL treated over five years at South Egypt Cancer Institute (SECI), Assiut University, between January 2005 and January 2010. The data of every patient included: Age, sex, and presentation, staging work up to determine extent of the disease and the type of resection performed, histopathological examination, details of chemotherapy, disease free survival and overall survival. The study included 25 boys and 10 girls with a median age of six years (range: 2.5:15). Thirty patients (86%) presented with abdominal pain, 23 patients (66%) presented with abdominal mass and distention, 13 patients (34%) presented with weight loss, and intestinal obstruction occurred in six patients (17%). The ileo-cecal region and abdominal lymph nodes were the commonest sites (48.5%, 21% respectively). Burkitt's lymphoma was the most common histological type in 29 patients (83%). Ten (28.5%) stage II (group A) and 25 (71.5%) stage III (group B). Complete resections were performed in 10 (28.5%), debulking in 6 (17%) and imaging guided biopsy in 19 (54%). A11 patients received systemic chemotherapy. The median follow up duration was 63 months (range 51-78 months). The parameters that significantly affect the overall survival were stage at presentation complete resection for localized disease. In conclusion, the extent of disease at presentation is the most important prognostic factor in pediatric abdominal NHL. Surgery is restricted to defined situations such as; abdominal emergencies, diagnostic biopsy and total tumor extirpation in localized disease. Chemotherapy is the cornerstone in the management of pediatric abdominal NHL.<\/jats:p>","DOI":"10.3390\/cancers3021593","type":"journal-article","created":{"date-parts":[[2011,3,29]],"date-time":"2011-03-29T11:23:26Z","timestamp":1301397806000},"page":"1593-1604","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Role of Surgery in Stages II and III Pediatric Abdominal Non-Hodgkin Lymphoma: A 5-Years Experience"],"prefix":"10.3390","volume":"3","author":[{"given":"Amany M.","family":"Ali","sequence":"first","affiliation":[{"name":"Pediatric Oncology Department, South Egypt Cancer Institute, Assiut University, Asyut, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba A.","family":"Sayd","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Department, South Egypt Cancer Institute, Assiut University, Asyut, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham M.","family":"Hamza","sequence":"additional","affiliation":[{"name":"Surgical Oncology Department, South Egypt Cancer Institute, Assiut University, Asyut, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Salem","sequence":"additional","affiliation":[{"name":"Surgical Oncology Department, South Egypt Cancer Institute, Assiut University, Asyut, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2011,3,29]]},"reference":[{"key":"ref_1","unstructured":"Patte, C. (2004). Pediatric Oncology, Arnold. [3th ed.]."},{"key":"ref_2","unstructured":"Pizzo, P.A., and Poplack, D.G. (2002). Principles and Practice of Pediatric Oncology, J.B. Lippincott Co."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1053\/jpsu.2002.35417","article-title":"The role of surgery in the treatment of pediatric b-cell non-hodgkin's lymphoma","volume":"37","author":"Andishe","year":"2002","journal-title":"J. Pediatric. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1200\/JCO.1989.7.2.186","article-title":"Non-hodgkin's lymphomas of childhood: An analysis of the histology, staging, and response to treatment of 338 cases at a single institution","volume":"7","author":"Murphy","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"ref_5","unstructured":"Ebeid, E., Iman, S., and Eldydy, M. (2003, January 17-18). Risk -adapted treatment of burkitt's lymphoma in children. Cairo, Egypt."},{"key":"ref_6","unstructured":"Khairy, A., El-Sissy, A., Fahmy, A., Labeeb, Y., and El-Sebaie, M. (2003, January 17-18). Burkitt' lymphoma in children; an overview. Cairo, Egypt. Abstract books."},{"key":"ref_7","first-page":"2337","article-title":"Non hodgkin lymphoma in children","volume":"2","author":"Cairo","year":"2003","journal-title":"Cancer"},{"key":"ref_8","first-page":"978","article-title":"Malignant non hodgkin 's lymphoma of childhood and adolescence in austria-therapy results between 1988 and 2000","volume":"114","author":"Attarbaschi","year":"2002","journal-title":"Wien Klin Wochenschr"},{"key":"ref_9","first-page":"583","article-title":"Pediatric nhl in children: Diagnosis and current management","volume":"38","author":"Vats","year":"2001","journal-title":"Indian Pediatrics"},{"key":"ref_10","unstructured":"Jaffe, E., Stein, H., Vardiman, J., and World health organization classification of tumors (2000). Tumors Hematopoietic Lymphoid Tissues, WHO."},{"key":"ref_11","unstructured":"(2005). Manual of Pediatric Hematology and Oncology, Academic Press. [4th ed.]."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0022-3468(92)90318-2","article-title":"The role of surgery in abdominal nhl: Experience from the children cancer study group","volume":"27","author":"LaQuaglia","year":"1992","journal-title":"J. Pediatric Surg."},{"key":"ref_13","first-page":"555","article-title":"Surgical resection in the treatment of primary gastrointestinal nhl, retrospective study","volume":"43","author":"Radman","year":"2002","journal-title":"Croat Med. J."},{"key":"ref_14","first-page":"294","article-title":"Improved treatment results in childhood b-cell neoplasms with tailored intensification of therapy: A report of the berlin-frankfurt-munster group trial nhl-bfm 90","volume":"94","author":"Reiter","year":"1999","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJM199605093341906","article-title":"Crist, Non-hodgkin's lymphoma in childhood","volume":"334","author":"John","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1054\/bjoc.1999.1083","article-title":"Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): Results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol","volume":"82","author":"Atra","year":"2000","journal-title":"Br. J. Cancer"},{"key":"ref_17","unstructured":"Sema, V., Kebudi, R., Akycy, F., Tokuc, G., Omer, G., Aydodan, G., Dodan, O., and Ayan, Y. (2003, January 17-18). Results of the modified BFM-NHML 90 chemotherapy regimen in children with advanced stage nonlymphoblastic lymphoma. Cairo, Egypt."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/jcp.50.2.128","article-title":"Childhood non-hodgkin lymphomas in the united kingdom: Findings from the uk children's cancer study group","volume":"50","author":"Wright","year":"1997","journal-title":"J. Clin. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/1096-911X(200007)35:1<8::AID-MPO2>3.0.CO;2-P","article-title":"Improved outcome in children B-cell lymphoma with intensified french lmb protocol","volume":"35","author":"Yaniv","year":"2002","journal-title":"Med. Pediatric Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/3\/2\/1593\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:55:40Z","timestamp":1760219740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/3\/2\/1593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,29]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,6]]}},"alternative-id":["cancers3021593"],"URL":"https:\/\/doi.org\/10.3390\/cancers3021593","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,29]]}}}